Education + Advocacy = Change

Click a topic below for an index of articles:

New-Material

Home

Donate

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

 

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

 

 

 

 

  


 

Zinc 


 

Introduction

Zinc is an important element that is found in every cell in the body. More than 300 enzymes in the body need zinc in order to function properly. Although the amount of zinc we need in our daily diet is tiny, it's very important that we get it. However, the evidence suggests that many of us do not get enough. Mild zinc deficiency seems to be fairly common.

Severe zinc deficiency can cause a major loss of immune function, and mild zinc deficiency might impair immunity slightly. For this reason, making sure to get enough zinc may help keep you from catching colds or other infections. But zinc may be helpful for colds in a completely different way, too, by directly interfering with viruses in the nose or throat. For this purpose, it is used either as a nasal spray or in the form of lozenges taken every 2 hours from the first sign of cold symptoms.

Intriguing evidence suggests that zinc supplements may have other specific benefits as well, including helping stomach ulcers heal, relieving symptoms of rheumatoid arthritis, slightly improving acne symptoms, increasing sperm count, aiding recovery from anorexia nervosa, improving growth rate in children with sickle-cell disease, and preventing "sickle-cell crisis" (a serious condition in people with sickle-cell anemia).

Requirements/Sources

The official U.S. recommendations for daily intake of zinc are as follows:

  • Infants 0-6 months, 2 mg
    7-12 months, 3 mg
  • Children 1-3 years, 3 mg
    4-8 years, 5 mg
  • Males 9-13 years, 8 mg
    14 years and older 11 mg
  • Females 9-13 years, 8 mg
    14-18 years, 9 mg
    19 years and older, 8 mg
  • Pregnant women, 11 mg (13 mg if 18 years old or younger)
  • Nursing women, 12 mg (14 mg if 18 years old or younger)

The average diet in the developed world commonly provides insufficient zinc, especially in women, adolescents, infants, and the elderly.1-5 Thus, it may be a wise idea to increase your intake of zinc on general principles.

Individuals with alcoholism, sickle-cell anemia, diabetes, or kidney disease are also thought to be at increased risk for zinc deficiency.

Various drugs may also inhibit zinc absorption, including captopril and possibly other ACE inhibitors, drugs which reduce stomach acid (including H2 blockers and proton pump inhibitors), and oral contraceptives.6-12 Certain nutrients may have the same effect, such as calcium, soy, manganese, copper, and iron.13-29 Contrary to previous reports, folate is not likely to significantly affect zinc absorption.30

Thiazide diuretics ("water pills") can cause excessive loss of zinc in the urine.31,32

Oysters are by far the best food source of zinca single serving will give you about 10 times the recommended daily intake! Seeds and nuts, peas, whole wheat, rye, and oats are not nearly as high in zinc, but you can get about 3 mg per serving of these foods.

Zinc can also be taken as a nutritional supplement, in one of many forms. Zinc citrate, zinc acetate, or zinc picolinate may be the best absorbed, although zinc sulfate is less expensive. When you purchase a supplement, you should be aware of the difference between the milligrams of actual zinc the product contains (so-called elemental zinc) and the total milligrams of the zinc product. All figures given in this article refer to the amount of actual zinc to take.

Therapeutic Dosages

For most purposes, zinc should simply be taken at the recommended daily requirements listed previously. For best absorption, zinc supplements should not be taken at the same time as high-fiber foods;33,34 however, many high-fiber foods provide zinc in themselves.

When taking zinc long term it is advisable to take 1 to 3 mg of copper daily as well, because zinc supplements can cause copper deficiency.35,36 Zinc may also interfere with magnesium37 and iron38 absorption.

For treatment of colds, much higher doses of zinc are used, although only for a short period of time. The usual dosage is 13 to 23 mg of zinc as zinc gluconate every 2 hours for a week or two (but no longer). The purpose is not to increase zinc levels in your body, but to interfere with the action of viruses in the back of your throat (or, in the case of zinc nasal spray, in the nose). It appears that of the common forms of zinc, only zinc gluconate and zinc acetate have the required antiviral properties.39,40 Also, some sweeteners and flavorings used in lozenges can block zinc's antiviral action. Dextrose, sucrose, mannitol, and sorbitol appear to be fine, but citric acid and tartaric acid are not. The information on glycine as a flavoring agent is a bit equivocal.

Long-term use of relatively high-dose zinc (90 mg daily or more) has been tried for various conditions such as acne, sickle-cell anemia, and rheumatoid arthritis, but medical supervision is essential because of the risk of toxicity (see Safety Issues).

Therapeutic Uses

Good evidence suggests that if you take zinc lozenges every 2 hours at the beginning of a cold, you will recover much more quickly.41 One study suggests that zinc nasal spray may be even more effective.42 These methods supply a high dose of zinc for a short time, and are thought to work by directly interfering with viruses in the nose and throat. Zinc can also be taken at nutritional doses orally to improve immunity;43,44 however, this approach probably only works if you are deficient in zinc to begin with.

Topical zinc may also be helpful for cold sores.45

Pregnant women should make sure to get enough zinc. One large double-blind study in zinc-deficient pregnant women found that a standard zinc supplement could significantly improve the birth weight and head size of their newborn children.46 However, zinc supplements failed to make any difference in another large double-blind study of pregnant women that did not specifically select zinc-deficient women.47

Evidence also suggests that zinc can reduce symptoms of acne,48-53 although most studies used high, possibly toxic, doses of zinc.

Growing evidence suggests that zinc, especially in combination with antioxidants, can help slow the progression of macular degeneration.105,106,156

Zinc may also improve growth rate in children with sickle cell anemia161 and help prevent the development of sickle-cell crisis.54 Zinc might also speed the healing of stomach ulcers.55,56

Zinc has been tested as a treatment for rheumatoid arthritis with mixed results;57-62,159,160 overall, the evidence is not encouraging.

Some, but not all, studies have found that HIV-positive individuals tend to be deficient in zinc, with levels dropping lower in more severe disease.64-69 Higher zinc levels have been linked to better immune function and higher CD4+ cell counts, whereas zinc deficiency has been linked to increased risk of dying from HIV.70,71,72 One preliminary study among people taking AZT found that 30 days of zinc supplementation led to decreased rates of opportunistic infection over the following 2 years.73 However, other research has linked higher zinc intake to more rapid development of AIDS.74,75 The bottom line: If you have HIV, consult your physician before supplementing with zinc.

Preliminary evidence from two small, double-blind trials suggests that zinc supplements might be helpful in treating anorexia nervosa, possibly enhancing weight gain and helping stabilize mood.81,82,162 One frequently quoted study often used to discredit the use of zinc in anorexia appears to be relatively meaningless when inspected closely.83,162

One small uncontrolled study found that zinc supplements increased sperm counts and improved fertility for men with low testosterone levels.76 But no such effect was seen in men whose testosterone levels were normal to begin with.

Although the evidence that it works is not yet meaningful, zinc is sometimes recommended for the following conditions as well: Alzheimer's disease,77-80attention deficit disorder, benign prostatic hyperplasia,87-93bladder infection, cataracts, diabetes,94,95,96 Down's syndrome,97,98,99impotence,100 inflammatory bowel disease (ulcerative colitis and Crohn's disease),101-104osteoporosis,107periodontal disease, prostatitis,108psoriasis, tinnitus,109,110 and wound and burn healing.111,112,113

An 8-week double-blind trial of zinc at the somewhat high dose of 67 mg daily failed to find any benefit for eczema symptoms.158

What Is the Scientific Evidence for Zinc?

Colds

Numerous studies have evaluated the effects of zinc lozenges or zinc nasal spray for colds. Most found positive results, as long as the right form of zinc is used (zinc gluconate or acetate).

In a double-blind placebo-controlled trial, 213 individuals with a newly starting cold used one squirt of zinc gluconate gel or placebo gel in each nostril every 4 hours while awake.114 The results were dramatic: Treated participants stayed sick an average of 2.3 days, while those receiving placebo were sick for an average of 9 days, a whopping 75% reduction in the duration of symptoms.

A more recent study found no benefits with zinc nasal spray. In this double-blind placebo-controlled trial, 185 individuals who had just started to develop cold symptoms were given either a zinc spray or placebo.115 No benefits were seen in the treated group as compared to the placebo group. However, this study used a much lower amount of zinc per squirt of spray than that of the positive study: 50 times lower to be exact. In addition, the spray contained zinc sulfate rather than zinc gluconate. The exact chemical form of zinc appears to markedly influence its ability to kill cold viruses (see below).

Zinc lozenges also appear to be helpful. For example, in a double-blind trial, 100 people who were experiencing the early symptoms of a cold were given a lozenge that either contained 13.3 mg of zinc from zinc gluconate or was just a placebo.116 Participants took the lozenges several times daily until their cold symptoms subsided. The results were impressive. Coughing disappeared within 2.2 days in the treated group versus 4 days in the placebo group. Sore throat disappeared after 1 day versus 3 days in the placebo group, nasal drainage in 4 days (versus 7 days), and headache in 2 days (versus 3 days).

Positive results have also been seen in double-blind studies of zinc acetate.117,118

Not all studies have shown such positive results.119 However, the overall results appear to be favorable.120 It has been suggested that the exact formulation of the zinc lozenge plays a significant role. Flavoring agents, such as citric acid and tartaric acid, appear to prevent zinc from inhibiting viruses, and chemical forms of zinc other than zinc gluconate or zinc acetate may not work.121 Sweeteners such as sorbitol, sucrose, dextrose, and mannitol are fine, but the information on glycine as a flavoring agent is equivocal.

Besides using zinc to directly interfere with viruses, supplementation at nutritional dosages may also help reduce the frequency of colds by strengthening your overall health.

In a 2-year study of nursing home residents, participants given zinc and selenium developed illnesses much less frequently than those given placebo.122 Of course, it isn't clear from this study which was more helpful, the zinc or the selenium. However, we do know that chronic zinc deficiency weakens the immune system,123 and studies performed in developing countries using zinc alone have found benefits. For example, a 6-month double-blind placebo-controlled study of 609 preschool children in India found that zinc supplementsreduced the rate of respiratory infections by 45%.124 Nine other studies have also found zinc supplements helpful for preventing illness.125

  


 

Cold Sores

Cold sores are infections caused by the herpes virus. One study suggests that topical zinc may be helpful. In this trial, 46 individuals with cold sores were treated with a zinc oxide cream or placebo every 2 hours until cold sores resolved.126 The results showed that individuals using the cream experienced a reduction in severity of symptoms and a shorter time to full recovery.

Zinc is thought to interfere with the ability of the herpes virus to reproduce itself. As with colds, the formulation of zinc must be properly designed to release active zinc ions. This study used a special zinc oxide and glycine formulation.

Some participants in this study experienced burning and inflammation caused by the zinc itself, but this seldom caused a serious problem.

Acne

Studies suggest that people with acne have lower-than-normal levels of zinc in their bodies.127,128,129 This fact alone does not prove that taking zinc supplements will help acne, but several small double-blind studies involving a total of over 300 people have found generally positive results.

In one of these studies, 54 people were given either placebo or 135 mg of zinc as zinc sulfate daily. Zinc produced slight but measurable benefits.130 Similar results have been seen in other studies using 90 to 135 mg of zinc daily.131-134 One study suggests that a lower and safer dose, 30 mg daily, may also be helpful.135 In some studies, however, no benefits were seen.136,137

Two studies have compared zinc against a standard treatment for acne, the antibiotic tetracycline. One found that zinc was as effective as tetracycline taken at 250 mg daily,138 but another found the antibiotic far more effective when taken at 500 mg daily.139

Keep in mind that the dosages of zinc used in most of these studies are rather high, and should be used only under a physician's supervision.

Sickle-Cell Anemia

Children with sickle cell disease often do not grow normally. In a placebo-controlled study, 42 children with sickle cell disease (age 4 to 10) were given either zinc supplements (10 mg zinc daily) or placebo for a period of 1 year.161 Results showed that by the end of the study, the participants given zinc showed enhanced growth compared to those given placebo. It is not clear whether participants were actually deficient in zinc or simply benefited from the zinc supplement regardless of deficiency.

Unfortunately, (and inexplicably) this study does not appear to have been double-blind, which makes the results less than fully reliable.

Zinc may also be helpful in preventing "sickle-cell crisis" in individuals with sickle-cell anemia.140 A double-blind placebo-controlled study treated 145 sickle-cell subjects with either 220 mg of zinc sulfate 3 times daily or placebo. During 18 months of treatment, the zinc-treated subjects had an average of 2.5 crises, compared to 5.3 for the placebo group. However, zinc didn't seem to reduce the severity of a crisis, as measured by the number of days spent in the hospital for each crisis.

Warning: Sickle-cell anemia is far too serious a condition to self-treat, and the relatively high dosages of zinc used in this study should be taken only under the supervision of a doctor (see Safety Issues).

Macular Degeneration

Macular degeneration is one of the most common causes of vision loss in the elderly.

A double-blind placebo-controlled trial evaluated the effects of zinc with or without antioxidants on the progression of macular degeneration in 3,640 individuals in the early stage of the disease.156 Participants were randomly assigned to receive one of the following: antioxidants (vitamin C 500 mg, vitamin E 400 IU, and beta-carotene 15 mg), zinc (80 mg) and copper (2 mg), antioxidants plus zinc, or placebo. (Copper was administered along with zinc to prevent zinc-induced copper deficiency.)

The results suggest that zinc (alone or, even better, with antioxidants) significantly slowed the progression of the disease.

Previous studies of zinc for macular degeneration found mixed results, but they were much smaller.141,142

Keep in mind that the dosages of zinc used in most of these studies are rather high, and should be used only under a physician's supervision.

In addition, there is some evidence that making sure to get your dietary requirement of zinc on a daily basis over many years might reduce the risk of developing macular degeneration later in life.143

-Safety Issues

Zinc seldom causes any immediate side effects other than occasional stomach upset, usually when it's taken on an empty stomach. Some forms do have an unpleasant metallic taste.

However, long-term use of zinc at dosages of 100 mg or more daily can cause a number of toxic effects, including severe copper deficiency, impaired immunity, heart problems, and anemia.144-147 The U.S. government has issued recommendations regarding "tolerable upper intake levels" (ULs) for zinc. The UL can be thought of as the highest daily intake over a prolonged time known to pose no risks to most members of a healthy population. The ULs for zinc are as follows:157

  • Infants 0-6 months, 4 mg
    7-12 months, 5 mg
  • Children 1 to 3 years, 7 mg
    4 to 8 years, 12 mg
    9 to 13 years, 23 mg
  • Males and females 14 to 18 years, 34 mg
    19 years and older, 40 mg
  • Pregnant or nursing women, 40 mg (34 mg if 18 years old or younger)

Use of zinc can interfere with the absorption of penicillamine antibiotics in the tetracycline or fluoroquinolone (Cipro, Floxin) families.148-153

The potassium-sparing diuretic amiloride was found to significantly reduce zinc excretion from the body.154 This means that if you take zinc supplements at the same time as amiloride, zinc accumulation could occur. This could lead to toxic side effects. However, the potassium-sparing diuretic triamterene does not seem to cause this problem.155

Interactions You Should Know About

If you are taking

  • Medications that reduce stomach acid such as Zantac (ranitidine) or Prilosec (omeprazole); ACE inhibitors; oral contraceptives; estrogen-replacement therapy; thiazide diuretics; calcium; copper; or iron: You may need to take extra zinc.
  • Manganese, antacids, soy, or antibiotics in the fluoroquinolone (e.g., Cipro, Floxin) or tetracycline families: It may be advisable to separate your doses of zinc and these substances by at least 2 hours.
  • Zinc supplements: You should also take extra copper, and perhaps magnesium as well because zinc interferes with their absorption. Zinc interferes with iron absorption, too, but you shouldn't take iron supplements unless you know you are deficient.
  • Penicillamine: Zinc interferes with penicillamine's absorption so it may be advisable to take zinc and penicillamine at least 2 hours apart.
  • Amiloride: It could reduce zinc excretion from the body, leading to zinc accumulation, which could cause toxic side effects. Do not take zinc supplements unless advised by a physician.
  


 

References

1. Sandstead HH. Zinc nutrition in the United States. Am J Clin Nutr. 1973;26:1251-1260.

2. Prasad AS. Role of zinc in human health. Bol Asoc Med PR. 1991;83:558-560.

3. Prasad AS. Zinc deficiency in women, infants, and children. J Am Coll Nutr. 1996;15:113-120.

4. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc supplementation on pregnancy outcome. JAMA. 1995;274:463-468.

5. Stang J, Story MT, Harnack L, et al. Relationships between vitamin and mineral supplement use, dietary intake, and dietary adequacy among adolescents. J Am Diet Assoc. 2000;100:905-910.

6. Baum MK, Javier JJ, Mantero-Atienza E, et al. Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infected homosexual males. J Acquir Immune Defic Syndr. 1991;4:1218-1226.

7. Golik A, Modai D, Averbukh Z, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism. 1990;39:665-667.

8. Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr. 1998;17:75-78.

9. Sturniolo GC, Montino MC, Rossetto L, et al. Inhibition of gastric acid secretion reduces zinc absorption in man. J Am Coll Nutr. 1991;10:372-375.

10. Reyes AJ, Olhaberry JV, Leary WP, et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J. 1983;64:936-941.

11. Reyes AJ, Leary WP, Lockett CJ, et al. Diuretics and zinc. S Afr Med J. 1982;62:373-375.

12. Webb JL. Nutritional effects of oral contraceptive use: a review. J Reprod Med. 1980;25:150-156.

13. Argiratos V, Samman S. The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects. Eur J Clin Nutr. 1994;48:198-204.

14. Spencer H, Kramer L, Norris C, et al. Effect of calcium and phosphorus on zinc metabolism in man. Am J Clin Nutr. 1984;40:1213-1218.

15. Dawson-Hughes B, Seligson FH, Hughes VA. Effects of calcium carbonate and hydroxyapatite on zinc and iron retention in postmenopausal women. Am J Clin Nutr. 1986;44:83-88.

16. Spencer H, Norris C, Osis D. Further studies of the effect of zinc on intestinal absorption of calcium in man. J Am Coll Nutr. 1992;11:561-566.

17. Crowther RS, Marriott C. Counter-ion binding to mucus glycoproteins. J Pharm Pharmacol. 1984;36:21-26.

18. Hwang S-J, Lai YH, Chen HC, et al. Comparisons of the effects of calcium carbonate and calcium acetate on zinc tolerance test in hemodialysis patients. Am J Kidney Dis. 1992;19:57-60.

19. Pecoud A, Donzel P, Schelling JL. Effect of foodstuffs on the absorption of zinc sulfate. Clin Pharmacol Ther. 1975;17:469-474.

20. Navert B, Sandstrom B, Cederblad A. Reduction of the phytate content of bran by leavening in bread and its effect on zinc absorption in man. Br J Nutr. 1985;53:47-53.

21. Vohra P, Gray GA, Kratzer FH. Phytic acid-metal complexes. Proc Soc Exp Biol Med. 1965;120:447-449.

22. Sandstrom B, Davidsson L, Cederblad A, et al. Oral iron, dietary ligands and zinc absorption. J Nutr. 1985;115:411-414.

23. Meadows NJ, Grainger SL, Ruse W, et al. Oral iron and the bioavailability of zinc. Br Med J (Clin Res Ed). 1983;287:1013-1014.

24. Solomons NW, Jacob RA. Studies on the bioavailability of zinc in humans: effects of heme and nonheme iron on the absorption of zinc. Am J Clin Nutr. 1981;34:475-482.

25. Davidsson L, Almgren A, Sandstrom B, et al. Zinc absorption in adult humans: the effect of iron fortification. Br J Nutr. 1995;74:417-425.

26. Newhouse IJ, Clement DB, Lai C. Effects of iron supplementation and discontinuation on serum copper, zinc, calcium, and magnesium levels in women. Med Sci Sports Exerc. 1993;25:562-571.

27. Aggett PJ, Crofton RW, Khin C, et al. The mutual inhibitory effects on their bioavailability of inorganic zinc and iron. Prog Clin Biol Res. 1983;129:117-124.

28. Scott KC, Turnlund JR. A compartmental model of zinc metabolism in adult men used to study effects of three levels of dietary copper. Am J Physiol. 1994;267: E165-E173.

29. Freeland-Graves JH. Manganese: an essential nutrient for humans. Nutr Today. 1988;23:13-19.

30. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr. 1989;50:353-358.

31. Reyes AJ, Leary WP, Lockett CJ, et al. Diuretics and zinc. S Afr Med J. 1982;62:373-375.

32. Reyes AJ, Olhaberry JV, Leary WP, et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J. 1983;64:936-941.

33. Navert B, Sandstrom B, Cederblad A. Reduction of the phytate content of bran by leavening in bread and its effect on zinc absorption in man. Br J Nutr. 1985;53:47-53.

34. Vohra P, Gray GA, Kratzer FH. Phytic acid-metal complexes. Proc Soc Exp Biol Med. 1965;120:447-449.

35. Hoffman HN II, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology. 1988;94:508-512.

36. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr. 1995;61(suppl 3):621S-624S.

37. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man. J Am Coll Nutr. 1994;13:479-484.

38. Yadrick MK, Kenney MA, Winterfeldt EA. Iron, copper, and zinc status: Response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr. 1989;49:145-150.

39. Marshall S. Zinc gluconate and the common cold. Review of randomized controlled trials. Can Fam Physician. 1998;44:1037-1042.

40. Eby GA. Zinc ion availabilitythe determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother. 1997;40:483-493.

41. Marshall S. Zinc gluconate and the common cold. Review of randomized controlled trials. Can Fam Physician. 1998;44:1037-1042.

42. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J. 2000;79:778-781.

43. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab. 1997;41:98-107.

44. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials. J Pediatr. 1999;135:689-697.

45. Godfrey HR, Godfrey NJ, Godfrey JC, et al. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med. 2001;7:49-54, 56.

46. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc supplementation on pregnancy outcome. JAMA. 1995;274:463-468.

47. Jonsson B, Hauge B, Larsen MF, et al. Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand. 1996;75:725-729.

48. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69:541-543.

49. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. 1978;58:443-448.

50. Verma KC, Saini AS, Dhamija SK. Oral zinc sulfate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60:337-340.

51. Weimar VM, Puhl SC, Smith WH, et al. Zinc sulfate in acne vulgaris. Arch Dermatol. 1978;114:1776-1778.

52. Hillstrom L, Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol. 1977;97:681-684.

53. Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol. 1977;113:31-36.

54. Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crisis in sickle-cell anemia: a double-blind, randomized controlled clinical trial. J Assoc Physicians India. 1995;43:467-469.

55. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust. 1975;2:793-796.

56. Garcia-Plaza A, Arenas JI, Belda O, et al. A multicenter clinical trial. Zinc acexamate versus famotidine in the treatment of acute duodenal ulcer [in Spanish; English abstract]. Rev Esp Enferm Dig. 1996;88:757-762.

57. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents Actions Suppl. 1981;8:587-596.

58. Pandey SP, Bhattacharya SK, Sundar S. Zinc in rheumatoid arthritis. Indian J Med Res. 1985;81:618-620.

59. Mattingly PC, Mowat AG. Zinc sulphate in rheumatoid arthritis. Ann Rheum Dis. 1982;41:456-457.

60. Rasker JJ, Kardaun SH. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis. Scand J Rheumatol. 1982;11:168 -170.

61. Dixon JS, Bird HA, Martin MF, et al. Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs. Int J Clin Pharmacol Res. 1985;5:25-33.

62. Job C, Menkes CJ, Delbarre F. Zinc sulphate in the treatment of rheumatoid arthritis. Arthritis Rheum. 1980;23:1408-1409.

63. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate. Agents Actions Suppl. 1981;8:587-596.

64. Fabris N, Mocchegiani E, Galli M, et al. AIDS, zinc deficiency, and thymic hormone failure [letter]. JAMA. 1988;259:839-840.

65. Sappey C, Leclercq P, Coudray C, et al. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta. 1994;230:35-42.

66. Odeh M. The role of zinc in acquired immunodeficiency syndrome. JIntern Med. 1992;231:463-469.

67. Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1-infected children. AIDS. 1995;9:887-893.

68. Tomaka FL, Imoch PJ, Reiter WM, et al. Prevalence of nutritional deficiencies in patients with HIV Infection [abstract]. Int Conf AIDS. 1994;10:221.

69. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9:1051-1056.

70. Campa A, Lai H, Shor-Posner G, et al. Relationship between zinc deficiency and survival in HIV+ homosexual men [abstract]. FASEB J. 1998;12:A217.

71. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9:1051-1056.

72. Bogden JD, Kemp FW, Han S, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr. 2000;72:809-815.

73. Mocchegiani E, Rivabene R, Santini MT. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int JImmunopharmacol. 1995;17:719-727.

74. Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am JEpidemiol. 1993;138:937-951.

75. Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am JEpidemiol. 1996;143:1244-1256.

76. Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch Androl. 1981;7:69-73.

77. Constantinidis J. Alzheimer's disease: the zinc theory [in French; English abstract]. Encephale. 1990;16:231-239.

78. Constantinidis J. The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Med Hypotheses. 1991;35:319-323.

79. Cuajungco MP, Lees GJ. Zinc metabolism in the brain: Relevance to human neurodegenerative disorders. Neurobiol Dis. 1997;4:137-169.

80. Lovell MA, Robertson JD, Teesdale WJ, et al. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 1998;158:47-52.

81. Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord. 1994;15:251-255.

82. Katz RL, Keen CL, Litt IF, et al. Zinc deficiency in anorexia nervosa. J Adolesc Health Care. 1987;8:400-406.

83. Lask B, Fosson A, Rolfe U, et al. Zinc deficiency and childhood-onset anorexia nervosa. J Clin Psychiatry. 1993;54:63-66.

84. Roijen SB, Worsaae U, Zlotnik G. Zinc in patients with anorexia nervosa [in Danish; English abstract]. Ugeskr Laeger. 1991;153:721-723.

85. Ward NI. Assessment of zinc status and oral supplementation in anorexia nervosa. J Nutr Med. 1990;1:171-177.

86. Castillo-Duran C, Heresi G, Fisberg M, et al. Controlled trial of zinc supplementation during recovery from malnutrition: effects on growth and immune function. Am J Clin Nutr. 1987;45:602-608.

87. Bandlish U, Prabhakar BR, Wadehra PL. Plasma zinc level estimation in enlarged prostate. Indian J Pathol Microbiol. 1988;31:231-234.

88. Gonick P, Oberleas D, Knechtges T, et al. Atomic absorption spectrophotometric determination of zinc in the prostate. Invest Urol. 1969;6:345-347.

89. Schrodt GR, Hall T, Whitmore WF. The concentration of zinc in diseased human prostate glands. Cancer. 1964;17:1555-1566.

90. Gyorkey F, Min KW, Huff JA, et al. Zinc and magnesium in human prostate gland: normal, hyperplastic and neoplastic. Cancer Res. 1967;27:1348-1353.

91. Gyorkey F, Sato CS. In vitro 65Zn-binding capacities of normal, hyperplastic, and carcinomatous human prostate gland. Exp Mol Pathol. 1968;8:216-224.

92. Leake A, Chisholm GD, Habib FK. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. J Steroid Biochem. 1984;20:651-655.

93. Leake A, Chrisholm GD, Busuttil A, et al. Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction. Acta Endocrinol (Copenh). 1984;105:281-288.

94. Schmidt LE, Arfken CL, Heins JM. Evaluation of nutrient intake in subjects with non-insulin-dependent diabetes mellitus. J Am Diet Assoc. 1994;94:773-774.

95. Blostein-Fujii A, DiSilvestro RA, Frid D, et al. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr. 1997;66:639-642.

96. Rauscher AM, Fairweather-Tait SJ, Wilson PD, et al. Zinc metabolism in non-insulin dependent diabetes mellitus. J Trace Elem Med Biol. 1997;11:65-70.

97. Sustrova M, Strbak V. Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy. J Endocrinol Invest. 1994;17:385-390.

98. Licastro F, Mocchegiani E, Masi M, et al. Modulation of the neuroendocrine system and immune functions by zinc supplementation in children with Down's syndrome. J Trace Elem Electrolytes Health Dis. 1993;7:237-239.

99. Lockitch G, Puterman M, Godolphin W, et al. Infection and immunity in Down syndrome: a trial of long-term low oral doses of zinc. J Pediatr. 1989;114:781-787.

100. Rodger RS, Sheldon WL, Watson MJ, et al. Zinc deficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uraemia. Nephrol Dial Transplant. 1989;4:888-892.

101. Sjogren A, Floren CH, Nilsson A. Evaluation of zinc status in subjects with Crohn's disease. J Am Coll Nutr. 1988;7:57-60.

102. Van de Wal Y, Van der Sluys Veer A, Verspaget HW, et al. Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease. Aliment Pharmacol Ther. 1993;7:281-286.

103. Mulder TP, van der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 1994;9:472-477.

104. Dronfield MW, Malone JD, Langman MJ. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels. Gut.1977;18:33-36.

105. Stur M, Tittl M, Reitner A, et al. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.

106. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.

107. Relea P, Revilla M, Ripoll E, et al. Zinc, biochemical markers of nutrition, and type-I osteoporosis. Age Ageing. 1995;24:303-307.

108. Neal DE Jr, Kaack MB, Fussell EN, et al. Changes in seminal fluid zinc during experimental prostatitis. Urol Res. 1993;21:71-74.

109. Gersdorff M, Robillard T, Stein F, et al. The zinc sulfate overload test in patients suffering from tinnitus associated with low serum zinc. Preliminary report [in French; English abstract]. Acta Otorhinolaryngol Belg. 1987;41:498-505.

110. Paaske PB, Pederson CB, Kjems G, et al. Zinc therapy of tinnitus. A placebo-controlled study [in Danish; English abstract]. Ugeskr Laeger. 1990;152:2473-2475.

111. Han CM. Changes in body zinc and copper levels in severely burned patients and the effects of oral administration of ZnS04 by a double-blind method [in Chinese; English abstract]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1990;6:83-86, 155.

112. Agren MS, Stromberg HE, Rindby A, et al. Selenium, zinc, iron and copper levels in serum of patients with arterial and venous leg ulcers. Acta Derm Venereol. 1986;66:237-240.

113. Floersheim GL, Lais E. Lack of effect of oral zinc sulfate on wound healing in leg ulcer [in German; English abstract]. Schweiz Med Wochenschr. 1980;110:1138-1145.

114. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J. 2000;79:778-781.

115. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med. 2001;111:103-108.

116. Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold: a randomized, double-blind placebo-controlled study. Ann Intern Med. 1996;125:81-88.

117. Petrus EJ, Lawson KA, Bucci LR. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res. 1998;59:595-607.

118. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:245-252.

119. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA. 1998;279:1962-1967.

120. Marshall S. Zinc gluconate and the common cold. Review of randomized controlled trials. Can Fam Physician. 1998;44:1037-1042.

121. Eby GA. Linearity in dose-response from zinc lozenges in treatment of common colds. J Pharm Technol. 1995;11:110-122.

122. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab. 1997;41:98-107.

123. Sugarman B. Zinc and infection. Rev Infect Dis. 1983;5:137-147.

124. Sazawal S, Black RE, Jalla S, et al. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics. 1998;102:1-5.

125. Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials. J Pediatr. 1999;135:689-697.

126. Godfrey HR, Godfrey NJ, Godfrey JC, et al. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med. 2001;7:49-54, 56.

127. Pohit J, Saha KC, Pal B. Zinc status of acne vulgaris patients. J Appl Nutr. 1985;37:18-25.

128. Amer M, Bahgat MR, Tosson Z, et al. Serum zinc in acne vulgaris. Int J Dermatol. 1982;21:481-484.

129. Michaelsson G, Vahlquist A, Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol. 1977;96:283-286.

130. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. 1978;58:443-448.

131. Verma KC, Saini AS, Dhamija SK. Oral zinc sulfate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60:337-340.

132. Weimar VM, Puhl SC, Smith WH, et al. Zinc sulfate in acne vulgaris. Arch Dermatol. 1978;114:1776-1778.

133. Hillstrom L, Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol. 1977;97:681-684.

134. Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol. 1977;113:31-36.

135. Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69:541-543.

136. Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol. 1977;57:357-360.

137. Orris L, Shalita AR, Sibulkin D, et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol. 1978;114:1018-1020.

138. Michaelsson G, Juhlin L, Ljunghall K. A double-blind study of the effects of zinc and oxytetracycline in acne vulgaris. Br J Dermatol. 1977;97:561-566.

139. Cunliffe WJ, Burke B, Dodman B, et al. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol. 1979;101:321-325.

140. Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crisis in sickle-cell anemia: a double-blind, randomized controlled clinical trial. J Assoc Physicians India. 1995;43:467-469.

141. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.

142. Stur M, Tittl M, Reitner A, et al. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225-1235.

143. Mares-Perlman JA, Klein R, Klein BE, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.

144. Hoffman HN II, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology. 1988;94:508-512.

145. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr. 1995;61(suppl 3):621S-624S.

146. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225-227.

147. Porea TJ, Belmont JW, Mahoney DH Jr. Zinc-induced anemia and neutropenia in an adolescent. J Pediatr. 2000;136:688-690.

148. Lim D, McKay M. Food-drug interactions. Drug Information Bulletin (UCLA Dept. of Pharmaceutical Services). 1995;15(2).

149. Drug Evaluations Annual. Vol. 2. Milwaukee, Wis: American Medical Association; 1993.

150. Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11:45-54.

151. Mapp RK, McCarthy TJ. The effect of zinc sulphate and of bicitropeptide on tetracycline absorption. S Afr Med J. 1976;50:1829-1830.

152. Polk RE, Healy DP, Sahai J, et al. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989;33:1841-1844.

153. Campbell NR, Kara M, Hasinoff BB, et al. Norfloxacin interaction with antacids and minerals. Br J Clin Pharmacol. 1992;33:115-116.

154. Reyes AJ, Olhaberry JV, Leary WP, et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J. 1983;64:936-941.

155. Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand. 1980;208:209-212.

156. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report no.8. Arch Ophthalmol. 2001;119:1417-1436.

157. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2001). Available at www.nap.edu. Accessed October 4, 2001.

158. Ewing CI, Gibbs AC, Ashcroft C, et al. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr. 1991;45:507-510.

159. Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet. 1976;2:539-542.

160. Peretz A, Neve J, Jeghers O, et al. Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases. Am J Clin Nutr. 1993;57:690-694.

161. Zemel BS, Kawchak DA, Fung EB, et. al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr. 2002;75:300-307.

162. Su JC, Birmingham CL. Zinc supplementation in the treatment of anorexia nervosa. Eat Weight Disord. 2002;7:20-22.

 

 

 

Email: